Leaflet PREOTACT 100mcg powder and solvent for solution for injection

Product code:
W51659001
Quantity:
2
Indicated for:
hypoparathyroidism
Route of administration:
injectable
Substance:
parathyroid hormone (thyroid hormone)
ATC
H05AA03 — Systemic hormonal preparations, excluding sex hormones and insulins | Parathyroid hormones and analogues

Precautions:

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Parathyroid hormone (PTH) is used in the treatment of severe osteoporosis in patients at high risk of fractures. It stimulates bone formation by increasing osteoblast activity and improving calcium metabolism.

The medication is administered subcutaneously, as directed by a doctor, usually once daily. It is important for patients to follow the treatment regimen and undergo regular tests to monitor bone health.

Patients should be aware of potential side effects, such as nausea, joint pain, or dizziness. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, joint pain, and dizziness. In rare cases, severe reactions such as hypercalcemia or allergic reactions may occur. Patients should be informed of these risks before use.

General data about PREOTACT 100mcg

Substance:
parathyroid hormone
Date of latest medicines list:
01-07-2013
Product code:
W51659001
Concentration:
100mcg
Pharmaceutical form:
powder and solvent for solution for injection
Quantity:
2
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Concentrations available for parathyroid hormone

  • 100mcg
  • 100mcg/dose
  • 25mcg/dose
  • 50mcg/dose
  • 75mcg/dose